Top Pharmaceuticals companies in Italy by Gross Profit Margin

This ranking features the top 14 Pharmaceuticals companies in Italy ranked by Gross Profit Margin, averaging a Gross Profit Margin of 44.70%, for January 15, 2025.
#
Name
Gross Profit Margin
Reported Date
Stock Price
Change
Price (30 days) Country
1
100.00%
Dec. 31, 2023 USD 9.91 -0.63%

Italy

2
68.32%
Dec. 31, 2023 USD 54.26 0.70%

Italy

3
64.55%
Dec. 31, 2023 USD 103.47 -0.44%

Italy

4
53.01%
Dec. 31, 2023 USD 2.04 0.60%

Italy

5
48.45%
Dec. 31, 2023 USD 53.59 1.39%

Italy

6
43.81%
Dec. 31, 2023 USD 10.42 1.00%

Italy

7
43.14%
Dec. 31, 2023 USD 38.13 0.20%

Italy

8
41.81%
Dec. 31, 2023 USD 4.75 -0.90%

Italy

9
36.41%
Dec. 31, 2023 USD 11.22 0.24%

Italy

10
31.32%
Dec. 31, 2023 USD 21.65 -1.23%

Italy

11
26.90%
Dec. 31, 2023 USD 7.71 1.97%

Italy

12
24.51%
Dec. 31, 2023 USD 19.32 1.97%

Italy

13
22.58%
Dec. 31, 2023 USD 4.68 -0.92%

Italy

14
20.94%
Dec. 31, 2023 USD 10.47 -1.53%

Italy

Frequently Asked Questions
  • Which Pharmaceuticals company in Italy has the highest Gross Profit Margin ?

    The Pharmaceuticals company in Italy with the highest Gross Profit Margin is Newron Pharmaceuticals S.p.A. (XETRA: NP5.DE) at 100.00%.

  • Which Pharmaceuticals company in Italy has the lowest Gross Profit Margin ?

    The Pharmaceuticals company in Italy with the lowest Gross Profit Margin is GPI S.p.A. (Milan Stock Exchange: GPI.MI) at 20.94%.